April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Up-regulation Of Syndecan Expression May Be A Viral-induced Mechanism For HSV-1 Shedding
Author Affiliations & Notes
  • Deepak Shukla
    Ophthalmology/Visual Sciences,
    University of Illinois at Chicago, Chicago, Illinois
  • Ghadah Karasneh
    Ophthalmology/Visual Sciences,
    University of Illinois at Chicago, Chicago, Illinois
  • Sarolta Bacsa
    Ophthalmology/Visual Sciences,
    University of Illinois at Chicago, Chicago, Illinois
  • Tibor Valyi-Nagy
    Pathology,
    University of Illinois at Chicago, Chicago, Illinois
  • Footnotes
    Commercial Relationships  Deepak Shukla, None; Ghadah Karasneh, None; Sarolta Bacsa, None; Tibor Valyi-Nagy, None
  • Footnotes
    Support  NIH Grant AI057860 and RPB Lew R. Wasserman Merit Award to DS
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5866. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Deepak Shukla, Ghadah Karasneh, Sarolta Bacsa, Tibor Valyi-Nagy; Up-regulation Of Syndecan Expression May Be A Viral-induced Mechanism For HSV-1 Shedding. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5866.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate novel molecular mechanism(s) that may promote HSV-1 detachment and shedding from cells.

Methods: : Wild-type HSV-1(KOS) was examined for ability to alter the expression of syndecan-1, a heparan sulfate (HS) proteoglycan to which the HSV-1 binds during attachment to cells. RNA interference was used for down-regulating syndecan-1 expression. Virus shedding was determined by plaque assays upon treatment with syndecan shedding agonist (phorbol ester PMA) or antagonist (tyrphostin A25). Protein expression in corneal epithelial and other cell-types was examined by flow cytometry and Western blot analysis. Antibody treatments were used for probing the activity of syndecan-1 in HSV-1 infection cycle. A time course assay was performed to determine syndecan-1 and heparan sulfate expression upon HSV-1 (KOS) infection.

Results: : HSV-1 infection is accompanied by a constant increase in syndecan-1 expression. However, the increase in syndecan expression, which is an attachment co-receptor for HSV-1, does not result in an increased ability of the virus to infect cells. In contrast, the infectivity of HSV-1 goes down with the passage of time. Our data suggests that ongoing HSV-1 infection results in an increase in syndecan-1 shedding rate, which is likely meant to facilitate virus detachment or shedding from cell surfaces. To support this result, a syndecan shedding agonist enhanced virus release (shedding) by more than 30%. Overall, the virus yield was significantly enhanced by the syndecan shedding agonist (PMA) treatment.

Conclusions: : HSV-1 is able to enhance syndecan-1 expression upon infection. However, the enhanced syndecan-1 expression fails to correlate with enhanced infectivity. In contrast, it correlates well with enhanced syndecan-1 shedding and stronger HSV-1 release from the infected cells. We propose that the increase in syndecan-1 expression is a novel, previously unreported, molecular mechanism by which HSV-1 facilitates its detachment and hence, shedding from the cells of the cornea.

Keywords: herpes simplex virus • receptors • glycoconjugates/glycoproteins 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×